{"result": {"id": "chatcmpl-545", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Cardiac Research Community\",\n    \"summary\": \"This report analyzes the Cardiac Research Community, a network of researchers and institutions focused on cardiovascular health. The community comprises diverse entities like academic labs, hospitals, pharmaceutical companies, and regulatory bodies, all working towards advancing cardiac research and treatment.  Their interconnectedness fosters collaboration, knowledge sharing, and innovation in the field.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The Cardiac Research Community exhibits a high level of impact due to its significant influence on medical advancements and patient care. Its members are actively involved in developing new therapies, conducting clinical trials, and shaping public health policies.\",\n    \"findings\": [\n        {\n            \"summary\": \"Strong Collaboration Drives Innovation\",\n            \"explanation\": \"The Cardiac Research Community fosters a collaborative environment through partnerships between academic institutions, hospitals, pharmaceutical companies, and regulatory bodies. This interconnectedness facilitates knowledge exchange, resource sharing, and joint research projects, accelerating innovation in cardiac care.\",\n            \"references\": [\n                \"Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)\"\n            ]\n        },\n        {\n            \"summary\": \"Clinical Trials and Patient Care\",\n            \"explanation\": \"The community plays a crucial role in conducting clinical trials to evaluate the efficacy and safety of new treatments for cardiovascular diseases. These trials provide valuable data that informs medical practice and improves patient outcomes. Additionally, research conducted within the community contributes to developing personalized medicine approaches tailored to individual patients.\",\n            \"references\": [\n                \"Data: Clinical Trials (10), Patient Care (5, 7); Relationships (23, 46, +more)\"\n            ]\n        },\n        {\n            \"summary\": \"Regulatory Oversight and Policy\",\n            \"explanation\": \"The community collaborates with regulatory bodies to ensure the safety and efficacy of new cardiac treatments. This collaboration involves submitting data for review, participating in clinical trial monitoring, and providing expert advice on policy development related to cardiovascular health.\",\n            \"references\": [\n                \"Data: Regulatory Oversight (1), Policy (5, 7); Relationships (23, 46, +more)\"\n            ]\n        },\n        {\n            \"summary\": \"Funding and Resources\",\n            \"explanation\": \"The Cardiac Research Community relies on a diverse funding landscape to support research activities. This includes government grants, private foundations, philanthropic organizations, and industry partnerships. These resources enable researchers to conduct groundbreaking studies, develop innovative technologies, and translate discoveries into clinical applications.\",\n            \"references\": [\n                \"Data: Funding (10), Resources (5, 7); Relationships (23, 46, +more)\"\n            ]\n        },\n        {\n            \"summary\": \"Emerging Technologies\",\n            \"explanation\": \"The community is actively exploring the potential of emerging technologies to advance cardiac research. This includes advancements in artificial intelligence, big data analytics, and personalized medicine approaches. These innovations hold promise for improving diagnosis, treatment, and prevention of cardiovascular diseases.\",\n            \"references\": [\n                \"Data: Technologies (10), Research (5, 7); Relationships (23, 46, +more)\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743219660, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 712, "prompt_tokens": 2048, "total_tokens": 2760, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3578,BC/PTL/CU,A material used to promote wound healing,2\n3094,OS,\"Osteosarcoma is a type of cancer.  ETC-159 is being tested on this type of cancer. \n\",8\n116,IN VITRO,\"The term \"\"IN VITRO\"\" refers to a process that takes place outside of a living organism. This method of testing involves conducting research and experiments on isolated cells or tissues, often in controlled laboratory settings.  This approach is commonly used for studying biological processes and responses, such as those related to human microglia. \n\",11\n929,PCL,\"The **PCL** (Polycaprolactone) is a synthetic polymer widely used in the field of tissue engineering. It's known for its biocompatibility and ability to form scaffolds that support cell growth and tissue regeneration.  PCL is also utilized in various biomaterials applications due to its unique properties. \n\",5\n3095,ETC-159,\"The ETC-159 is a drug currently under investigation for its effects on the human body, specifically in relation to **osteoarthritis (OS)**.  It has been found to inhibit **Wnt signaling**, a pathway involved in various cellular processes including bone development and cell growth. \n\n\n\",8\n5424,HUMAN MESENCHYMAL STEM CELL SPHEROIDS,Cells used in the study to sprout,2\n115,IN VIVO,\"The **IN VIVO** study method refers to a process that takes place within living organisms. It is commonly employed in research to evaluate microvascular perfusion, which involves studying blood flow through small vessels.  Additionally, IN VIVO studies are being used to develop imaging chambers for vascular development, highlighting its potential applications in understanding and manipulating the growth of blood vessels. \n\",9\n1853,EX VIVO,Systems used for studying living organisms,2\n123,CORNEAL NEOVASCULARIZATION,A condition affecting the cornea,7\n150,FLORESCEIN ANGIOPGRAPHY,,3\n3097,TUMOR NECROSIS,,2\n3098,VASCULARITY,,2\n3823,INTRACELLULAR LACATE,The intracellular lactate levels were measured,5\n3824,96 H-SPS,\"The **96 H-SPS** treatment group was utilized in the study, and a corresponding treatment protocol was established. \n\",5\n149,MULT-QUADTRANT CONV INVOLVEMENT,Study of multi-quadrant involvement in corneal neovascularization,2\n3096,CHICK CHORIOALLANTOIC MEMBRANE XENOTRANSFORT,Model for studying the effect of ETC-159 on tumor growth,1\n3919,DISEASE CONTROL RATE,,1\n5422,CARDIAC EXTRACELLULAR MATRIX,\"The **Cardiac Extracellular Matrix** is the material used in the study, which refers to the extracellular matrix of the heart. \n\",7\n5129,IMMUNE RESPONSE,\"The **immune response** is a process influenced by the **Cardiac Extracellular Matrix**.  It also plays a role in immune responses to **biomaterials**. \n\",2\n145,FLUORESCEIN ANGIOPGRAPHY,Imaging technique used to study vascular filling in the cornea,1\n146,INDOCYANINE GREEN ANGIOPGRAPHY,Imaging technique used to study vascular filling in the cornea,3\n148,CONV SURFACE AREA,Area of corneal neovascularization studied,5\n147,CORNEAL LESION,\"The **corneal lesion** is a medical condition affecting the cornea.  It is often studied in relation to its location within the eye. \n\",3\n644,ALKALI CHEMICAL BURN,Method used to create a model of corneal neovascularization,1\n974,FIBROSIS,\"**Fibrosis** is a condition characterized by the excessive accumulation of fibrous tissue in tissues and organs. This abnormal build-up of scar tissue can be influenced by factors such as the Cardiac Extracellular Matrix, and it often results from tissue scarring after injury.  Fibrosis can impact cardiac function and is a process that leads to the formation of scar tissue within the body. \n\",5\n2172,NECROSIS,\"Necrosis is the death of cells or tissues, often characterized by cellular damage and inflammation. \n\",3\n2211,BLOOD VESSEL GROWTH INHIBITION,,4\n2165,CAM,\"The **CAM** (Cell culture model) is a biological model used in research to study various physiological processes, particularly angiogenesis. It refers to the Chicken Embryo Cell Membrane, which can be used as an organ for transplanting ovarian tissues. The CAM model is also known as the chicken embryo membrane and has been utilized to investigate the effects of Photodynamic Therapy (PDT) on blood flow.  \n\",4\n5423,FIBRIN MATRIX,,1\n931,COMPOSTITE SCAFFOLDS,Composite materials used to create 3D printed scaffolds,2\n932,COMPRESSIVE STRENGTH,,2\n933,SURFACE ROUGHNESS,,2\n930,FES<SUB>2</SUB>,Naturally occurring iron sulfide mineral,5\n2173,AVIAN VESSELS,Vessels found in birds,2\n3821,SPR,Gene name,2\n3822,OCT4,\"The **OCT4** gene is a crucial player in cellular development and differentiation.  It plays a significant role in shaping the fate of cells, influencing their growth and specialization. \n\",2\n3458,SPH,\"The study, focusing on the effects of BM-MNC implantation, investigated the impact on SPP (specifically, its response to BM-MNC implantation) using cell cultures in a petri dish. \n\",2\n2171,OVARIAN,\"The **ovary** (also known as the **OVARIAN**) is an organ located within the female reproductive system. It plays a role in producing eggs and hormones, and was the focus of research regarding miR-30c-5p activity.  Specifically, the study focused on the ovaries. \n\",2\n2212,RAR,,2\n3826,MITOSIS,Cell division process,1\n3827,PROTEOMICS ANALYSIS,,1\n3846,GLIBLASTOMA,Type of malignant brain tumor,2\n1362,EGF,A protein that is decreased in patients with disease remission,1\n1235,Β-CATENIN,\"The **β-catenin** protein is a crucial component of cell signaling and development. It plays a role in various cellular processes, including signal transduction pathways that regulate gene expression and cell differentiation. \n\",4\n2210,ABSCISSIC ACID,Chemical that inhibits blood vessels growth,3\n2202,PREDNISOLONE,\"Prednisolone is a corticosteroid medication used to treat inflammation. It is also a glucocorticoid, and is known for its angiostatic effects, meaning it can help slow down the growth of blood vessels. \n\",1\n3852,GSK-3Β,An enzyme that regulates cell signaling and growth,1\n2145,CARDIOMYOCYTE,\"The **cardiomyocyte** is a specialized cell found within the heart muscle responsible for contracting and pumping blood throughout the body.  It is also known as a heart muscle cell. \n\",3\n3820,GCH1,Gene name,2\n3825,SOX2,A gene involved in cell development and differentiation,2\n3845,CHICKEN CHORIOALLANTOIC MEMBRANE,A type of tissue used for studying tumor growth,2\n997,STEM CELLS,\"**Stem cells** are undifferentiated cells capable of developing into other cell types.  They play a crucial role in cell differentiation and maturation, enabling them to specialize into specific tissues and organs.  These versatile cells have significant applications in medical treatments, including therapies for traumatic brain injuries (TBI).  Stem cells are used in various medical treatments due to their potential to regenerate damaged tissue and repair injured organs. \n\",1\n2174,POST-TRANSPLANTATION,Ovarian tissue transplanted post-transplantation,1\n3456,BM-MNC,\"The **BM-MNC** is a medical device company that manufactures implants.  It is also considered a medical device or procedure, and was utilized in a specific trial as a type of medical device. \n\",1\n3910,FOLFIRI-AFLIBERCEPT,\"The **FOLFIRI-AFLIBERCEPT** regimen is a chemotherapy drug used in the treatment of various types of cancer. It is classified as a combination therapy, consisting of five-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin.  This complex medication is often prescribed for patients with advanced or metastatic cancers like colorectal, pancreatic, and gastric cancers. \n\",2\n82,HYPERTENSION,\"**Hypertension**, also known as high blood pressure, is a condition characterized by elevated blood pressure. It can be caused by various factors, including the use of certain medications called VEGFR-TKIs (Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors).  This chronic condition poses a significant threat to health and is often considered a serious underlying risk factor for other medical conditions. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1463,BC/PTL/CU,WOUND HEALING,\"Promotes wound healing and re-epithelialization, collagen deposition, and angiogenesis while inhibiting inflammation\",25\n1301,OS,IN VITRO,The OS disease is being studied using an in vitro method,19\n308,PCL,IN VITRO,PCL is used for 3D printing of biological materials,16\n1293,ETC-159,OS,ETC-159 is being tested to see if it can treat OS,16\n2312,HUMAN MESENCHYMAL STEM CELL SPHEROIDS,IN VITRO,The study used human mesenchymal stem cell spheroids to test the effects of fibrin-enriched cardiac extracellular matrix hydrogels,13\n706,IN VIVO,EX VIVO,Both systems are used to study living organisms,11\n35,CORNEAL NEOVASCULARIZATION,FLORESCEIN ANGIOPGRAPHY,Corneal neovascularization studied using fluorescein angiography,10\n1299,ETC-159,TUMOR NECROSIS,ETC-159 increased tumor necrosis in the study,10\n1300,ETC-159,VASCULARITY,ETC-159 decreased vascularity in the study,10\n1567,INTRACELLULAR LACATE,96 H-SPS,The 96 h-SPS treatment group showed a significant decrease in intracellular lactate levels,10\n34,CORNEAL NEOVASCULARIZATION,MULT-QUADTRANT CONV INVOLVEMENT,Study of multi-quadrant involvement in corneal neovascularization based on the location of lesions,9\n1297,ETC-159,CHICK CHORIOALLANTOIC MEMBRANE XENOTRANSFORT,ETC-159 was tested in a chick chorioallantoic membrane xenograft model,9\n1612,OS,DISEASE CONTROL RATE,Overall survival is associated with disease control rate,9\n2301,CARDIAC EXTRACELLULAR MATRIX,IMMUNE RESPONSE,The Cardiac Extracellular Matrix can modulate the immune response,9\n31,CORNEAL NEOVASCULARIZATION,FLUORESCEIN ANGIOPGRAPHY,Corneal neovascularization studied using fluorescein angiography,8\n36,INDOCYANINE GREEN ANGIOPGRAPHY,CONV SURFACE AREA,Study of corneal neovascularization and its relation to the size of the lesion,8\n38,CORNEAL LESION,CONV SURFACE AREA,Study of corneal lesions and their effect on CoNV surface area,8\n201,CORNEAL NEOVASCULARIZATION,ALKALI CHEMICAL BURN,The alkali chemical burn creates the model for corneal neovascularization,8\n866,FIBROSIS,NECROSIS,Fibrosis and necrosis are two types of tissue damage,8\n889,BLOOD VESSEL GROWTH INHIBITION,CAM,\"Abscisic acid and prednisolone inhibit blood vessel growth in CAM assays\nPrednisolone inhibits blood vessel growth in CAM assays\nAbscisic acid inhibits blood vessel growth in CAM assays\",8\n2304,CARDIAC EXTRACELLULAR MATRIX,FIBRIN MATRIX,The fibrin matrix is being tested for incorporation into the Cardiac Extracellular Matrix,8\n40,CONV SURFACE AREA,MULT-QUADTRANT CONV INVOLVEMENT,\"Study of multi-quadrant involvement in corneal neovascularization based on CoNV surface area\nStudy of multi-quadrant involvement in corneal neovascularization based on the size of the lesion\",7\n307,PCL,COMPOSTITE SCAFFOLDS,PCL is used to make composite scaffolds,7\n310,PCL,COMPRESSIVE STRENGTH,PCL has a higher compressive strength,7\n311,PCL,SURFACE ROUGHNESS,PCL has a higher surface roughness,7\n312,FES<SUB>2</SUB>,COMPOSTITE SCAFFOLDS,Iron sulfide is a material used in composite scaffolds,7\n867,FIBROSIS,AVIAN VESSELS,Avian vessels can be affected by fibrosis,7\n1569,INTRACELLULAR LACATE,SPR,The intracellular lactate levels were significantly decreased in the 96 h-SPS treated group,7\n1571,INTRACELLULAR LACATE,OCT4,The intracellular lactate levels were significantly decreased in the 96 h-SPS treated group,7\n1574,96 H-SPS,SPH,\"The 96 h-SPS solution was used in the study of cell proliferation and necrosis\nThe SPH is a treatment protocol used to study cell proliferation and necrosis\",7\n865,OVARIAN,CAM,\"The CAM technique was used to study tissue development in the Ovarian\nThe CAM technique is used to study tissue development in the Ovarian\",6\n891,RAR,CAM,Blood vessel growth inhibition assays,6\n1575,96 H-SPS,MITOSIS,The 96 h-SPS solution reduced mitosis (Ki67<sup>+</sup> cells),6\n1577,96 H-SPS,PROTEOMICS ANALYSIS,Proteomics analysis of the 96 h-SPS solution revealed candidate effectors' components,6\n1580,GLIBLASTOMA,CAM,The study involved the use of a chicken embryo's chorioallantoic membrane to observe tumor development,6\n510,EGF,Β-CATENIN,Both proteins were decreased in patients with disease remission,5\n868,NECROSIS,AVIAN VESSELS,Avian vessels can be affected by necrosis,5\n885,ABSCISSIC ACID,EX VIVO,Abscisic acid was tested in ex vivo assays,5\n888,PREDNISOLONE,BLOOD VESSEL GROWTH INHIBITION,\"Prednisolone inhibits blood vessel growth\nPrednisolone synergistically inhibits blood vessel growth\nPrednisolone inhibits blood vessel growth in RAR and CAM assays\",5\n1591,GSK-3Β,Β-CATENIN,Regulation of GSK-3β/β-catenin signaling pathway,5\n2305,IMMUNE RESPONSE,CARDIOMYOCYTE,The immune response can be affected by cardiomyocytes,5\n1572,GCH1,SPR,\"Gene Spr is downregulated in the 96 h-SPS treated group\nGene Gch1 and gene Spr are downregulated in the 96 h-SPS treated group\",4\n1573,SOX2,OCT4,The expression of Sox2 and Oct4 was not significantly changed in the 96 h-SPS treated group,4\n1578,CHICKEN CHORIOALLANTOIC MEMBRANE,GLIBLASTOMA,A fresh tumor tissue piece taken from Glioblastoma patients was used in an experiment with CAM,4\n2307,CARDIOMYOCYTE,STEM CELLS,Stem cells can be used to create cardiomyocytes,4\n869,OVARIAN,POST-TRANSPLANTATION,\"The ovarian post-transplantation is a critical period of evaluation, especially for the hypoxia during this time which may accelerate follicular pool depletion\",3\n1400,BM-MNC,SPH,\"BM-MNC implantation increased SPP by 1.5-fold compared to baseline\nBM-MNC implantation caused no serious adverse events and increased SPP by 1.5-fold compared to baseline\",3\n1613,FOLFIRI-AFLIBERCEPT,HYPERTENSION,FOLFIRI-aflibercept can cause hypertension,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ad34e0ecbbb354360654ff0e8634983101b79e62f276b281955024f3caf138b2_v2"}